Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 04:06:56 2024-05-07 pm EDT 5-day change 1st Jan Change
12.35 USD +6.01% Intraday chart for Hims & Hers Health, Inc. -1.00% +39.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday MT
Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating MT
Sector Update: Consumer MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $16 From $14, Maintains Hold Rating MT
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Traders Assess Earnings MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Tuesday; Palantir to Decline, Hims & Hers Health to Advance MT
Hims & Hers Health Swings to Q1 Earnings, Revenue Rises MT
Transcript : Hims & Hers Health, Inc., Q1 2024 Earnings Call, May 06, 2024
Earnings Flash (HIMS) HIMS & HERS HEALTH Posts Q1 Revenue $278.2M, vs. Street Est of $268.7M MT
Hims & Hers Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Hims & Hers Health, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 CI
Hims & Hers Health, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2024 CI
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline MT
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing MT
Seaport Global Starts Hims & Hers Health With Buy Rating MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target MT
Hims & Hers Appoints Christopher Payne as Newest Board Member CI
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $500,107, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $685,288, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $5,032,142, According to a Recent SEC Filing MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating MT
Hims & Hers Health Shares Jump After Q4 Beat MT
Chart Hims & Hers Health, Inc.
More charts
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
11.65 USD
Average target price
16.4 USD
Spread / Average Target
+40.81%
Consensus
  1. Stock Market
  2. Equities
  3. HIMS Stock
  4. News Hims & Hers Health, Inc.
  5. Seaport Global Starts Hims & Hers Health With Buy Rating
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW